National Research Corporation (NRC)
After hours:
| Previous close | 31.93 |
| Open | 32.34 |
| Bid | 32.43 x 1400 |
| Ask | 42.20 x 2200 |
| Day's range | 31.67 - 32.65 |
| 52-week range | 30.93 - 55.67 |
| Volume | |
| Avg. volume | 35,669 |
| Market cap | 820.33M |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 22.61 |
| EPS (TTM) | 1.44 |
| Earnings date | 01 Aug 2022 - 05 Aug 2022 |
| Forward dividend & yield | 0.96 (2.95%) |
| Ex-dividend date | 30 Mar 2022 |
| 1y target est | N/A |
- GlobeNewswire
National Research Corporation Announces Quarterly Dividend and Stock Repurchase Authorization
Lincoln, Nebraska, May 20, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health (the “Company”), (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.24 (twenty-four cents) per share payable Friday, July 15, 2022, to shareholders of record as of the close of business on Thursday, June 30, 2022. Also, on May 19, 2022, the Company’s Board of Directors approved a new stock repurchase authorization of up to 2.5 million shares of its common
- GlobeNewswire
National Research Corporation Announces Appointment to Board of Directors
Microsoft Executive Parul Bhandari Brings Digital Transformation Expertise to BoardLINCOLN, Neb., May 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, doing business as NRC Health (“NRC Health,” “NRC”, the “Company), the leading provider of in-depth customer insights in healthcare, today announced the appointment of Parul Bhandari to its Board of Directors, effective immediately. “Along with the rest of the Board, we are excited to share that Parul Bhandari has joined NRC Health as ou
- Simply Wall St.
National Research's (NASDAQ:NRC) five-year total shareholder returns outpace the underlying earnings growth
National Research Corporation ( NASDAQ:NRC ) shareholders might be concerned after seeing the share price drop 16% in...
